Evaluation of Prexasertib, a Checkpoint Kinase 1 Inhibitor, in a Phase Ib Study of Patients with Squamous Cell Carcinoma
暂无分享，去创建一个
Suzanne F. Jones | F. Meric-Bernstam | J. Bendell | H. Burris | J. Infante | D. Hong | R. Beckmann | C. Eng | S. Wijayawardana | W. William | S. Grant | Wei Zhang | A. Lin | L. Golden | K. Moore | M. Patel | R. Martinez